Clinical trial
ALL Adult Consortium Trial: Adult ALL Trial
NCT00476190 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00476190 |
|---|---|
| Title | ALL Adult Consortium Trial: Adult ALL Trial |
| Official title | ALL Adult Consortium Trial: Adult ALL Trial |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Massachusetts General Hospital Boston Children's Hospital NCIC Clinical Trials Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Doxorubicin, Cytarabine, Methotrexate, Vincristine, Cyclophosphamide, Methylprednisone, Hydrocortisone Sodium Succinate, Dexamethasone, 6-MP, PEG-Asparaginase and 4 more |
| Enrollment | 112 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Mar 1, 2020 |
| First posted | May 21, 2007 |
| Last update posted | Jun 12, 2025 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: